Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FS6NM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,895
Award facts
- Contract value 100% obligated
- $16,894.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,894.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of HUMIRA (Adalimumab) pen injectors at 40 mg/0.4 mL dosage. The contract is performance-based with an ultimate completion date of September 15, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement without set-aside provisions, demonstrating the vendor's capability to meet federal medical supply requirements in open competition. The company serves critical healthcare customers including the Defense Health Agency and U.S. Coast Guard through its DLA contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's significant role in the military's pharmaceutical supply chain and its ongoing partnership with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FS6NM?
SPE2DB25FS6NM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FS6NM worth?
The government has obligated $16,895 on SPE2DB25FS6NM.
Is contract SPE2DB25FS6NM an order under another contract?
Yes. SPE2DB25FS6NM is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6NM competed?
The extent of competition for SPE2DB25FS6NM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award